?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
Biosimilars 101
Policies
Biosimilars are a Free-Market Solution
The Biosimilar Access and Affordability Act
News
Resources
signalgroup
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
June 30, 2023
signalgroup
Delivering on a Watershed Moment for Biosimilars and Patients
News
April 10, 2023
signalgroup
Biosimilars Key to Lowering Healthcare and Prescription Drug Costs, According to Employers
News
March 30, 2023
signalgroup
Biosimilars Forum Applauds the U.S. Senate Finance Committee for Holding PBMs Accountable for Prioritizing Profits over Patients
News
March 3, 2023
signalgroup
Biosimilars Forum Applauds Congressman Hudson for Supporting Biosimilars
Through Shared Savings Legislation
News
January 31, 2023
signalgroup
The Biosimilars Forum Calls on Decisionmakers to Deliver on Humira Biosimilars
News
November 10, 2022
signalgroup
Dorothy McCabe Member Spotlight
News
November 3, 2022
signalgroup
Biosimilars Forum Wins Global Biosimilars Industry Partner of the Year at Global Generics & Biosimilars Awards
News
October 4, 2022
signalgroup
Biosimilars Forum Applauds CMS Biosimilars Measure
News
October 4, 2022
signalgroup
Inflation Reduction Act – ASP+8 Biosimilars Payment Increase
News
September 20, 2022
signalgroup
ASP +8: CMS Releases Biosimilars Information
Prev page
03
04
05
06
07
Next page